FBL promotes hepatocellular carcinoma tumorigenesis and progression by recruiting YY1 to enhance CAD gene expression
Yafei Zhi(Zhengzhou University), Kangdong Liu(Zhengzhou University), Nicholas R. Lemoine(Queen Mary University of London), Dengyun Zhao(Zhengzhou University), Xinyu He(Chinese Academy of Medical Sciences & Peking Union Medical College), Zigang Dong(China-US (Henan) Hormel Cancer Institute), Jinxin Xie(East China University of Science and Technology), Qiong Wu(Weifang Medical University), Honglin Li(Chengdu Institute of Biology), Yan Guo(Zhengzhou University), Shiliang Li(East China Normal University), Huifang Wei(Ningbo University of Technology), Kyle Vaughn Laster(China-US (Henan) Hormel Cancer Institute), Shanshan Ruan(East China University of Science and Technology)
Cited by 7
Related Papers
Blocking of tumor promoter-induced AP-1 activity inhibits induced transformation in JB6 mouse epidermal cells.
|Proceedings of the National Academy of Sciences|1994|388
NOREVA: enhanced normalization and evaluation of time-course and multi-class metabolomic data
|Nucleic Acids Research|2020|187
Coffee phenolic phytochemicals suppress colon cancer metastasis by targeting MEK and TOPK
|Carcinogenesis|2011|123
Epigallocatechin Gallate Suppresses Lung Cancer Cell Growth through Ras–GTPase-Activating Protein SH3 Domain-Binding Protein 1
|Cancer Prevention Research|2010|115
Phosphorylation of Histone H3 at Serine 10 Is Indispensable for Neoplastic Cell Transformation
|Cancer Research|2005|112